ARRY-162: Completed Phase II enrollment

Array completed enrollment of 201 patients in a 12-week, double-blind, placebo-controlled, international Phase II trial (162-201) evaluating 10 and 20 mg of oral ARRY-162 given twice daily and 40 mg o...